Based on the XOMA Corp stock forecast from 1 analysts, the average analyst target price for XOMA Corp is not available over the next 12 months. XOMA Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of XOMA Corp is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, XOMA Corp’s stock price was USD 19.97. XOMA Corp’s stock price has changed by +2.73% over the past week, -5.62% over the past month and -22.75% over the last year.
No recent analyst target price found for XOMA Corp
No recent average analyst rating found for XOMA Corp
Company Overview XOMA Corp
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Read Less
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. Th...Read More
Frequently Asked Questions About XOMA Corp (XOMA) Stock
Based on ratings from 1 analysts XOMA Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on XOMA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for XOMA is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .
XOMA stock's Price/Earning ratio is 24.56.
Our analysis grades XOMA stock's Price / Earning ratio at F. This means that XOMA stock's Price/Earning ratio is above 73% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this XOMA may be a overvalued for its sector.
The last closing price of XOMA's stock was USD 19.97.
The most recent market capitalization for XOMA is USD 0.25B.
Based on targets from 1 analysts, the average taret price for XOMA is projected at USD 0.00 over the next 12 months.
This means that XOMA's stock price may go up by +0.00% over the next 12 months.
We can't find any ETFs which contains XOMA Corp's stock.
As per our most recent records XOMA Corp has 13 Employees.
XOMA Corp's registered address is 2200 Powell Street, Emeryville, CA, United States, 94608.
You can get more information about it from XOMA Corp's website at https://www.xoma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About XOMA Corp (XOMA) Stock
Based on ratings from 1 analysts XOMA Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, sell and hold ratings.
Unfortunately we do not have enough data on XOMA's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for XOMA is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .
XOMA stock's Price/Earning ratio is 24.56.
Our analysis grades XOMA stock's Price / Earning ratio at F. This means that XOMA stock's Price/Earning ratio is above 73% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this XOMA may be a overvalued for its sector.
The last closing price of XOMA's stock was USD 19.97.
The most recent market capitalization for XOMA is USD 0.25B.
Based on targets from 1 analysts, the average taret price for XOMA is projected at USD 0.00 over the next 12 months.
This means that XOMA's stock price may go up by +0.00% over the next 12 months.
We can't find any ETFs which contains XOMA Corp's stock.
As per our most recent records XOMA Corp has 13 Employees.
XOMA Corp's registered address is 2200 Powell Street, Emeryville, CA, United States, 94608.
You can get more information about it from XOMA Corp's website at https://www.xoma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XOMA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
